Pavion Blue Capital’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$208K Buy
+7,422
New +$198K 0.09% 104
2025
Q4
Sell
-9,772
Closed -$249K 109
2025
Q3
$249K Sell
9,772
-15
-0.2% -$370 0.11% 93
2025
Q2
$237K Buy
9,787
+788
+9% +$18.4K 0.11% 93
2025
Q1
$228K Hold
8,999
0.11% 91
2024
Q4
$239K Hold
8,999
0.11% 89
2024
Q3
$260K Buy
+8,999
New +$263K 0.12% 85
2024
Q1
Sell
-6,987
Closed -$201K 102
2023
Q4
$201K Sell
6,987
-2,150
-24% -$65K 0.11% 96
2023
Q3
$303K Buy
9,137
+268
+3% +$9.48K 0.18% 73
2023
Q2
$325K Sell
8,869
-2,700
-23% -$105K 0.19% 72
2023
Q1
$472K Sell
11,569
-300
-3% -$13K 0.29% 64
2022
Q4
$608K Buy
11,869
+560
+5% +$26.8K 0.39% 55
2022
Q3
$495K Hold
11,309
0.35% 56
2022
Q2
$593K Hold
11,309
0.4% 54
2022
Q1
$585K Buy
11,309
+588
+5% +$30.5K 0.34% 54
2021
Q4
$633K Sell
10,721
-200
-2% -$9.91K 0.37% 54
2021
Q3
$470K Hold
10,921
0.29% 58
2021
Q2
$428K Sell
10,921
-161
-1% -$6.26K 0.26% 60
2021
Q1
$402K Hold
11,082
0.26% 58
2020
Q4
$408K Sell
11,082
-1,599
-13% -$58.7K 0.28% 59
2020
Q3
$442K Buy
12,681
+993
+8% +$34.8K 0.34% 57
2020
Q2
$363K Buy
11,688
+1,550
+15% +$52.7K 0.32% 55
2020
Q1
$314K Buy
+10,138
New +$345K 0.33% 57

Other funds holding PFE

Pavion Blue Capital's PFE Position: Q1 2026 in Review

Pavion Blue Capital opened a new position in Pfizer (PFE) in Q1 2026: 7,422 shares worth $208K. The stake represents 0.09% of the portfolio and ranks #104 among its holdings. This is a return to the name: Pavion Blue Capital previously reported a position in PFE as recently as Q3 2025.

Pavion Blue Capital first reported a position in PFE in Q1 2020 and has held it in 22 quarters since. The position peaked at $633K in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Pavion Blue Capital held 7,422 shares of Pfizer worth $208K as of Q1 2026.
  • Pfizer was a new Pavion Blue Capital position in Q1 2026.
  • Pfizer made up 0.09% of Pavion Blue Capital's portfolio in Q1 2026, its #104 holding.
  • Pavion Blue Capital first reported a position in Pfizer in Q1 2020 and has held it in 22 quarters since.
  • Pavion Blue Capital's Pfizer position peaked at $633K in Q4 2021.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Pavion Blue Capital's 13F filing for Q1 2026, filed 6 May 2026.